{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:32:49Z","timestamp":1793892769564,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Center for Population Medicine, Aarhus University","id":[{"id":"https:\/\/ror.org\/01aj84f44","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrent infections in the urinary tract may promote urologic cancer through chronic inflammation. However, evidence linking infections and the subsequent risk of urologic cancer has been conflicting, and long-term risk remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this population-based descriptive cohort study, we included all Danish adults with a first-time hospital discharge diagnosis of recurrent cystitis during 2006\u20132022 in the Danish National Patient Registry, excluding patients with prior cancer. Urologic cancer diagnoses were ascertained through the Danish Cancer Registry. We calculated cumulative incidences and standardised incidence ratios (SIRs) using incidence rates from the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 42,377 patients (68% women, median age 62 years), 1047 were diagnosed with urologic cancer (median follow-up 5.7 years). The 1-year risk of any urologic cancer was 1.2% (95% confidence interval [CI], 1.1\u20131.3%). The corresponding 1-year SIR was 4.99 (95% CI, 4.56\u20135.44). Beyond 2 years of follow-up, the SIR remained elevated among women only at 1.47 (95% CI, 1.20\u20131.78).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The elevated short-term risk suggests that recurrent cystitis is a clinical marker of urologic cancer. Yet, with low absolute risks, our results do not suggest additional diagnostic cancer work-up in these patients. In women, long-term risks for urologic cancer remained elevated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03591-y","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:42:39Z","timestamp":1787136159000},"page":"1666-1674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of urologic cancers in patients with hospital-diagnosed recurrent cystitis: a nationwide population-based study"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1965-0268","authenticated-orcid":false,"given":"Kasper Kjersgaard","family":"Mortensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstine Kobber\u00f8e","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra K\u00f6rmendin\u00e9","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-5891","authenticated-orcid":false,"given":"Mette","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-7040","authenticated-orcid":false,"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"3591_CR1","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1097\/01.ju.0000155595.98120.8e","volume":"173","author":"TL Griebling","year":"2005","unstructured":"Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in men. J Urol. 2005;173:1288\u201394.","journal-title":"J Urol"},{"key":"3591_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28:1\u201313.","journal-title":"Infect Dis Clin North Am"},{"key":"3591_CR3","unstructured":"Ferlay J, Laversanne M, Ervik M, Lam F, Colombet M, Mery L, et al. Global cancer observatory: cancer tomorrow (version 1.1). Lyon, France: International Agency for Research on Cancer [Internet]; 2024. Lyon, France; 2024 [cited 2024 Dec 11]. https:\/\/gco.iarc.who.int\/tomorrow. Accessed 11 Dec 2024."},{"key":"3591_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3591_CR5","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1080\/0284186X.2023.2263154","volume":"62","author":"M N\u00f8rgaard","year":"2023","unstructured":"N\u00f8rgaard M, Mailhac A, Fagerlund K, Strunz-McKendry T, Agerb\u00e6k M, Jensen JB. Treatment patterns, survival, and healthcare utilisation and costs in patients with locally advanced and metastatic bladder cancer in Denmark 2015\u20132020. Acta Oncol. 2023;62:1784\u201390.","journal-title":"Acta Oncol"},{"key":"3591_CR6","first-page":"1149","volume":"28","author":"M Sundaram","year":"2022","unstructured":"Sundaram M, Song Y, Rogerio JW, Zhang S, Bhattacharya R, Adejoro O, et al. Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: a retrospective analysis of Surveillance, Epidemiology, and End Results\u2013Medicare data. J Manag Care Spec Pharm. 2022;28:1149\u201360.","journal-title":"J Manag Care Spec Pharm"},{"key":"3591_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmi.2018.04.003","volume":"25","author":"KK S\u00f8gaard","year":"2019","unstructured":"S\u00f8gaard KK, Veres K, N\u00f8rgaard M, Djurhuus JC, S\u00f8rensen HT. Pyelonephritis in persons after age 50 as a clinical marker of urogenital cancer. Clin Microbiol Infect. 2019;25:87\u201391.","journal-title":"Clin Microbiol Infect"},{"key":"3591_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/aje\/kwh014","volume":"159","author":"AS Parker","year":"2004","unstructured":"Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP. History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol. 2004;159:42\u20138.","journal-title":"Am J Epidemiol"},{"key":"3591_CR9","doi-asserted-by":"publisher","first-page":"e0168254","DOI":"10.1371\/journal.pone.0168254","volume":"12","author":"C-Y Fan","year":"2017","unstructured":"Fan C-Y, Huang W-Y, Lin K-T, Lin C-S, Chao H-L, Yang J-F, et al. Lower urinary tract infection and subsequent risk of prostate cancer: a nationwide population-based cohort study. PLoS ONE. 2017;12:e0168254.","journal-title":"PLoS ONE"},{"key":"3591_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00053150","volume":"4","author":"N Kreiger","year":"1993","unstructured":"Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control. 1993;4:101\u201310.","journal-title":"Cancer Causes Control"},{"key":"3591_CR11","first-page":"275","volume":"72","author":"JK McLaughlin","year":"1984","unstructured":"McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF. A population-based case-control study of renal cell carcinoma. J Natl Cancer Inst. 1984;72:275\u201384.","journal-title":"J Natl Cancer Inst"},{"key":"3591_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/cas.12127","volume":"104","author":"L Sun","year":"2013","unstructured":"Sun L, Lin C, Liang J, Liu S, Sung F, Chang Y, et al. Urinary tract infection increases subsequent urinary tract cancer risk: a population-based cohort study. Cancer Sci. 2013;104:619\u201323.","journal-title":"Cancer Sci"},{"key":"3591_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/bjc.2014.601","volume":"112","author":"SH Vermeulen","year":"2015","unstructured":"Vermeulen SH, Hanum N, Grotenhuis AJ, Casta\u00f1o-Vinyals G, Van Der Heijden AG, Aben KK, et al. Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer. 2015;112:594\u2013600.","journal-title":"Br J Cancer"},{"key":"3591_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cmi.2022.10.020","volume":"29","author":"B Kjerulff","year":"2023","unstructured":"Kjerulff B, Kaspersen KA, Dinh KM, Boldsen J, Mikkelsen S, Erikstrup LT, et al. Smoking is associated with infection risk in healthy blood donors. Clin Microbiol Infect. 2023;29:506\u201314.","journal-title":"Clin Microbiol Infect"},{"key":"3591_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2023.03.002","volume":"91","author":"G Papavasileiou","year":"2023","unstructured":"Papavasileiou G, Tsilingiris D, Spyrou N, Vallianou NG, Karampela I, Magkos F, et al. Obesity and main urologic cancers: current systematic evidence, novel biological mechanisms, perspectives and challenges. Semin Cancer Biol. 2023;91:70\u201398.","journal-title":"Semin Cancer Biol"},{"key":"3591_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41366-021-01035-6","volume":"46","author":"G Pugliese","year":"2022","unstructured":"Pugliese G, Liccardi A, Graziadio C, Barrea L, Muscogiuri G, Colao A. Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. Int J Obes. 2022;46:449\u201365.","journal-title":"Int J Obes"},{"key":"3591_CR17","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00345-023-04406-y","volume":"41","author":"R Kumar","year":"2023","unstructured":"Kumar R, Matulewicz R, Mari A, Moschini M, Ghodoussipour S, Pradere B, et al. Impact of smoking on urologic cancers: a snapshot of current evidence. World J Urol. 2023;41:1473\u20139.","journal-title":"World J Urol"},{"key":"3591_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0966-842X(02)02360-0","volume":"10","author":"AJ Lax","year":"2002","unstructured":"Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002;10:293\u20139.","journal-title":"Trends Microbiol"},{"key":"3591_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR. NF-\u03baB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749\u201359.","journal-title":"Nat Rev Immunol"},{"key":"3591_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00428-015-1820-x","volume":"467","author":"G Nesi","year":"2015","unstructured":"Nesi G, Nobili S, Cai T, Caini S, Santi R. Chronic inflammation in urothelial bladder cancer. Virchows Arch. 2015;467:623\u201333.","journal-title":"Virchows Arch"},{"key":"3591_CR21","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.bjc.6604889","volume":"100","author":"X Jiang","year":"2009","unstructured":"Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata D, Conti DV, et al. Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer. 2009;100:834\u20139.","journal-title":"Br J Cancer"},{"key":"3591_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/oxfordjournals.aje.a113768","volume":"119","author":"AF Kantor","year":"1984","unstructured":"Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF. Urinary tract infection and risk of bladder cancer. Am J Epidemiol. 1984;119:510\u20135.","journal-title":"Am J Epidemiol"},{"key":"3591_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00345-018-2206-x","volume":"36","author":"S Akhtar","year":"2018","unstructured":"Akhtar S, Al-Shammari A, Al-Abkal J. Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case\u2013control and cohort studies. World J Urol. 2018;36:839\u201348.","journal-title":"World J Urol"},{"key":"3591_CR24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00345-018-2257-z","volume":"36","author":"CE Bayne","year":"2018","unstructured":"Bayne CE, Farah D, Herbst KW, Hsieh MH. Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis. World J Urol. 2018;36:1181\u201390.","journal-title":"World J Urol"},{"key":"3591_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00146885","volume":"3","author":"M McCredie","year":"1992","unstructured":"McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control. 1992;3:323\u201331.","journal-title":"Cancer Causes Control"},{"key":"3591_CR26","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<723::AID-IJC2>3.0.CO;2-1","volume":"66","author":"B Schlehofer","year":"1996","unstructured":"Schlehofer B, Pommer W, Mellemgaard A, Stewart JH, McCredie M, Niwa S, et al. International renal-cell-cancer study. VI. The role of medical and family history. Int J Cancer. 1996;66:723\u20136.","journal-title":"Int J Cancer"},{"key":"3591_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00053163","volume":"1","author":"R Talamini","year":"1990","unstructured":"Talamini R, Bar\u00f3n AE, Barra S, Bidoli E, La Vecchia C, Negri E, et al. A case-control study of risk factor for renal cell cancer in northern Italy. Cancer Causes Control. 1990;1:125\u201331.","journal-title":"Cancer Causes Control"},{"key":"3591_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.cej.0000198897.40303.d4","volume":"15","author":"C Pelucchi","year":"2006","unstructured":"Pelucchi C, Talamini R, Negri E, Franceschi S, Vecchia CL. Genital and urinary tract diseases and prostate cancer risk. Eur J Cancer Prev. 2006;15:254.","journal-title":"Eur J Cancer Prev"},{"key":"3591_CR29","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/ijc.32842","volume":"146","author":"A Potteg\u00e5rd","year":"2020","unstructured":"Potteg\u00e5rd A, Kristensen KB, Friis S, Hallas J, Jensen JB, N\u00f8rgaard M. Urinary tract infections and risk of squamous cell carcinoma bladder cancer: a Danish nationwide case\u2013control study. Int J Cancer. 2020;146:1930\u20136.","journal-title":"Int J Cancer"},{"key":"3591_CR30","doi-asserted-by":"publisher","first-page":"e002495","DOI":"10.1136\/bmjph-2024-002495","volume":"3","author":"F Jans\u00e5ker","year":"2025","unstructured":"Jans\u00e5ker F, Li X, Sundquist K. Acute cystitis and subsequent risk of urogenital cancer: a national cohort study from Sweden. BMJ Public Health. 2025;3:e002495.","journal-title":"BMJ Public Health"},{"key":"3591_CR31","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.3399\/BJGP.2022.0602","volume":"73","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Singh H, Hamilton W, Archer S, Tan S, Brimicombe J, et al. Improving the diagnostic process for patients with possible bladder and kidney cancer: a mixed-methods study to identify potential missed diagnostic opportunities. Br J Gen Pract. 2023;73:e575\u201385.","journal-title":"Br J Gen Pract"},{"key":"3591_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B. Urinary tract infection syndromes. Infect Dis Clin North Am. 2014;28:1\u201313.","journal-title":"Infect Dis Clin North Am"},{"key":"3591_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad332","volume":"10","author":"MP Bilsen","year":"2023","unstructured":"Bilsen MP, Jongeneel RMH, Schneeberger C, Platteel TN, Van Nieuwkoop C, Mody L, et al. Definitions of urinary tract infection in current research: a systematic review. Open Forum Infect Dis. 2023;10:ofad332.","journal-title":"Open Forum Infect Dis"},{"key":"3591_CR34","first-page":"424","volume":"24","author":"RD Malik","year":"2018","unstructured":"Malik RD, Wu YR, Zimmern PE. Definition of recurrent urinary tract infections in women: which one to adopt?. Urogynecology. 2018;24:424.","journal-title":"Urogynecology"},{"key":"3591_CR35","unstructured":"Ljungberg B, Albiges L, Bedke J, Bex A, Capitanio U, Giles R. EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid, Spain 2025. [Internet]. EAU Guidelines Office, Arnhem, The Netherlands; https:\/\/uroweb.org\/guidelines"},{"key":"3591_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CLEP.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, Sundb\u00f8ll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563\u201391.","journal-title":"Clin Epidemiol"},{"key":"3591_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"3591_CR38","doi-asserted-by":"crossref","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","DOI":"10.2147\/CLEP.S91125"},{"key":"3591_CR39","first-page":"535","volume":"44","author":"HH Storm","year":"1997","unstructured":"Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish cancer registry history, content, quality and use. Dan Med Bull. 1997;44:535\u20138.","journal-title":"Dan Med Bull"},{"key":"3591_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"3591_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8\u201335.","journal-title":"Psychother Psychosom"},{"key":"3591_CR42","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46:798\u2013798f.","journal-title":"Int J Epidemiol"},{"key":"3591_CR43","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","volume":"91","author":"JM Satagopan","year":"2004","unstructured":"Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91:1229\u201335.","journal-title":"Br J Cancer"},{"key":"3591_CR44","unstructured":"Rothman KJ, Boice HD, Austin H. Epidemiologic analysis with a programmable calculator. 2nd edn. Epidemiology Resources, Incorporated; 1982."},{"key":"3591_CR45","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical AssociationWorld Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"},{"key":"3591_CR46","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.3399\/BJGP.2023.0122","volume":"74","author":"G Funston","year":"2024","unstructured":"Funston G, Moullet M, Mounce L, Lyratzopoulos G, Walter FM, Zhou Y. Pre-diagnostic prescription patterns in bladder and renal cancer: a longitudinal linked data study. Br J Gen Pr. 2024;74:e149\u201355.","journal-title":"Br J Gen Pr"},{"key":"3591_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"3591_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/03008880802285032","volume":"42","author":"DM Parkin","year":"2008","unstructured":"Parkin DM. The global burden of urinary bladder cancer. Scand J Urol Nephrol. 2008;42:12\u201320.","journal-title":"Scand J Urol Nephrol"},{"key":"3591_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cncr.28416","volume":"120","author":"JA Cohn","year":"2014","unstructured":"Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer. 2014;120:555\u201361.","journal-title":"Cancer"},{"key":"3591_CR50","doi-asserted-by":"publisher","first-page":"e029143","DOI":"10.1136\/bmjopen-2019-029143","volume":"9","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, van Melle M, Singh H, Hamilton W, Lyratzopoulos G, Walter FM. Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review. BMJ Open. 2019;9:e029143.","journal-title":"BMJ Open"},{"key":"3591_CR51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djq099","volume":"102","author":"HG Welch","year":"2010","unstructured":"Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605\u201313.","journal-title":"J Natl Cancer Inst"},{"key":"3591_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07545-x","volume":"22","author":"CS Damhus","year":"2022","unstructured":"Damhus CS, Siersma V, Birkmose AR, Dalton SO, Brodersen J. Use and diagnostic outcomes of cancer patient pathways in Denmark\u2014is the place of initial diagnostic work-up an important factor?. BMC Health Serv Res. 2022;22:130.","journal-title":"BMC Health Serv Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03591-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:53:05Z","timestamp":1793890385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03591-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,11,20]]}},"alternative-id":["3591"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03591-y","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Department of Clinical Epidemiology, Aarhus University, receives funding for other studies in the form of institutional research grants to (and administered by) Aarhus University. The Department of Clinical Epidemiology, Aarhus University confirms that none of these studies have any relation to the present study. HTS has made paid evaluations for the University of Oslo, the Norwegian Research Council, the Independent Research Fund Denmark, the European Research Council, and EpidStrategies. KKM, KKS, DKF, EO and MN declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}